Loading...
Delayed methimazole-induced agranulocytosis in a 6-year old patient with Graves’ disease
BACKGROUND: Agranulocytosis is regarded as a rare side effect of methimazole (MMI) therapy that occurs in a dose dependent manner and that usually develops within the first 3–6 months of treatment. Although delayed development beyond this timeline has been documented in adults, very few children hav...
Na minha lista:
| Udgivet i: | Int J Pediatr Endocrinol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013617/ https://ncbi.nlm.nih.gov/pubmed/27605984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13633-016-0034-6 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|